Nabi Biopharmaceuticals to Present at Noble Financial's Sixth Annual Equity Conference
01. Juni 2010 15:45 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., June 1, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Dr. Raafat Fahim, President and Chief Executive Officer, will present at Noble Financial...
Nabi Biopharmaceuticals Announces First Quarter 2010 Financial Results
06. Mai 2010 16:02 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., May 6, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its first quarter financial results for the three month period ended March 27, 2010. The Company...
Nabi Biopharmaceuticals Announces First Quarter 2010 Financial Results Release Date
26. April 2010 13:45 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., April 26, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its first quarter 2010 financial results on Thursday, May 6, 2010, after...
Nabi Biopharmaceuticals Prevails in Opposition to Drug Abuse Therapy Patent
05. April 2010 16:52 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., April 5, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that the European Patent Office (EPO) upheld the Company's opposition to European Patent No....
Nabi Biopharmaceuticals Announces $61 Million Share Repurchase Program
23. März 2010 09:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., March 23, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that its Board of Directors has approved an aggregate total of up to $60.9 million to...
Nabi Biopharmaceuticals Initiates Second Phase III Study for NicVAX as an Aid to Smoking Cessation and Long-term Abstinence
17. März 2010 09:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., March 17, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced that it has initiated the second of two pivotal Phase III clinical trials for NicVAX® (Nicotine...
Nabi Biopharmaceuticals Announces Date for 2010 Annual Meeting of Shareholders
11. März 2010 14:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., March 11, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that its 2010 Annual Meeting of Shareholders will be held on Thursday, May 20, 2010 at 10:00...
Nabi Biopharmaceuticals Announces Fourth Quarter and Full-Year 2009 Financial Results
10. März 2010 16:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., March 10, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced fourth quarter and year-end financial results for the three and twelve month periods ended...
Nabi Biopharmaceuticals Closes NicVAX(R) Option and License Agreement
08. März 2010 09:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., March 8, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that the closing requirements set forth in the exclusive option and license agreement for...
Nabi Biopharmaceuticals to Announce 2009 Fourth Quarter and Year-End Financial Results on March 10, 2010
05. März 2010 11:30 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., March 5, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its 2009 fourth quarter and full-year financial results on Wednesday, March...